CIK 0001464521 · <br>Emerging growth company
Heartflow, Inc.
Sign in to watch- Ticker
- HTFL
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260506743
- Phone
- 650-241-1221
- Business address
- 135 MAIN STREET, SUITE 1000, SAN FRANCISCO, CA, 94105
- Former names
- Cardiovascular Simulation, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,602,722
- in 13 filings, $16.6M under 10b5-1 plans
Net −$16,602,722. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-11 | Lightcap Jeffrey C Director | Conversion | +4,615,542 | 4,615,542 | ||
| 2025-08-11 | Lightcap Jeffrey C Director | Conversion · Series C Preferred Stock | −624,471 | 0 | ||
| 2025-08-11 | Lightcap Jeffrey C Director | Conversion · Series C Preferred Stock | −1,248,939 | 0 | ||
| 2025-08-11 | Lightcap Jeffrey C Director | Conversion · Series D Preferred Stock | −1,630,231 | 0 | ||
| 2025-08-11 | Lightcap Jeffrey C Director | Conversion · Series D Preferred Stock | −208,604 | 0 | ||
| 2025-08-11 | Lightcap Jeffrey C Director | Conversion · Series E Preferred Stock | −1,099,378 | 0 | ||
| 2025-08-11 | Lightcap Jeffrey C Director | Conversion · Series F Preferred Stock | −1,337,337 | 0 | ||
| 2025-08-11 | Lightcap Jeffrey C Director | Conversion · Series F-1 Preferred Stock | −452,528 | 0 | ||
| 2025-08-11 | Lightcap Jeffrey C Director | Conversion · Convertible Promissory Note | −96,068 | 0 | ||
| 2025-08-07 | Cullivan Julie A Director | Grant or award · Stock Option | +23,710 | 23,710 | ||
| 2025-08-07 | WELDON WILLIAM C Director | Grant or award · Stock Option | +23,710 | 23,710 | ||
| 2025-08-07 | Riley Wayne Joseph Director | Grant or award · Stock Option | +23,710 | 23,710 | ||
| 2025-08-07 | Farquhar John C.M. Chief Executive Officer | Grant or award | +59,868 | 433,248 | ||
| 2025-08-07 | Farquhar John C.M. Chief Executive Officer | Grant or award · Stock Option | +314,603 | 314,603 | ||
| 2025-08-07 | Verghese Vikram Chief Financial Officer | Grant or award | +21,052 | 135,867 | ||
| 2025-08-07 | Verghese Vikram Chief Financial Officer | Grant or award · Stock Option | +110,629 | 110,629 | ||
| 2025-08-07 | Rogers Campbell Chief Medical Officer | Grant or award | +21,052 | 21,052 | ||
| 2025-08-07 | Rogers Campbell Chief Medical Officer | Grant or award · Stock Options | +110,629 | 110,629 | ||
| 2025-08-07 | Jones Marie L. Chief Accounting Officer, VP | Grant or award | +3,618 | 3,618 | ||
| 2025-08-07 | Jones Marie L. Chief Accounting Officer, VP | Grant or award · Stock Option | +19,014 | 19,014 |
Page 11 of 12 · 224 trades